IBDEI20J ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34150,1,4,0)
 ;;=4^Z99.81
 ;;^UTILITY(U,$J,358.3,34150,2)
 ;;=^5063760
 ;;^UTILITY(U,$J,358.3,34151,0)
 ;;=Z90.79^^131^1681^2
 ;;^UTILITY(U,$J,358.3,34151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34151,1,3,0)
 ;;=3^Acquired Absence of Genital Organs NEC
 ;;^UTILITY(U,$J,358.3,34151,1,4,0)
 ;;=4^Z90.79
 ;;^UTILITY(U,$J,358.3,34151,2)
 ;;=^5063596
 ;;^UTILITY(U,$J,358.3,34152,0)
 ;;=Z90.5^^131^1681^3
 ;;^UTILITY(U,$J,358.3,34152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34152,1,3,0)
 ;;=3^Acquired Absence of Kidney
 ;;^UTILITY(U,$J,358.3,34152,1,4,0)
 ;;=4^Z90.5
 ;;^UTILITY(U,$J,358.3,34152,2)
 ;;=^5063590
 ;;^UTILITY(U,$J,358.3,34153,0)
 ;;=Z90.2^^131^1681^6
 ;;^UTILITY(U,$J,358.3,34153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34153,1,3,0)
 ;;=3^Acquired Absence of Lung (part of)
 ;;^UTILITY(U,$J,358.3,34153,1,4,0)
 ;;=4^Z90.2
 ;;^UTILITY(U,$J,358.3,34153,2)
 ;;=^5063585
 ;;^UTILITY(U,$J,358.3,34154,0)
 ;;=Z98.1^^131^1681^10
 ;;^UTILITY(U,$J,358.3,34154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34154,1,3,0)
 ;;=3^Arthrodesis Status
 ;;^UTILITY(U,$J,358.3,34154,1,4,0)
 ;;=4^Z98.1
 ;;^UTILITY(U,$J,358.3,34154,2)
 ;;=^5063734
 ;;^UTILITY(U,$J,358.3,34155,0)
 ;;=Z94.7^^131^1681^16
 ;;^UTILITY(U,$J,358.3,34155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34155,1,3,0)
 ;;=3^Corneal Transplant Status
 ;;^UTILITY(U,$J,358.3,34155,1,4,0)
 ;;=4^Z94.7
 ;;^UTILITY(U,$J,358.3,34155,2)
 ;;=^5063661
 ;;^UTILITY(U,$J,358.3,34156,0)
 ;;=Z83.511^^131^1681^30
 ;;^UTILITY(U,$J,358.3,34156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34156,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,34156,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,34156,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,34157,0)
 ;;=Z80.52^^131^1681^33
 ;;^UTILITY(U,$J,358.3,34157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34157,1,3,0)
 ;;=3^Family Hx of Malig Neop of Baldder
 ;;^UTILITY(U,$J,358.3,34157,1,4,0)
 ;;=4^Z80.52
 ;;^UTILITY(U,$J,358.3,34157,2)
 ;;=^5063352
 ;;^UTILITY(U,$J,358.3,34158,0)
 ;;=Z80.51^^131^1681^36
 ;;^UTILITY(U,$J,358.3,34158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34158,1,3,0)
 ;;=3^Family Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,34158,1,4,0)
 ;;=4^Z80.51
 ;;^UTILITY(U,$J,358.3,34158,2)
 ;;=^321159
 ;;^UTILITY(U,$J,358.3,34159,0)
 ;;=Z83.41^^131^1681^43
 ;;^UTILITY(U,$J,358.3,34159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34159,1,3,0)
 ;;=3^Family Hx of Mult Endocrine Neoplasia Syndrome
 ;;^UTILITY(U,$J,358.3,34159,1,4,0)
 ;;=4^Z83.41
 ;;^UTILITY(U,$J,358.3,34159,2)
 ;;=^5063380
 ;;^UTILITY(U,$J,358.3,34160,0)
 ;;=Z81.8^^131^1681^50
 ;;^UTILITY(U,$J,358.3,34160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34160,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence,Psychoactive
 ;;^UTILITY(U,$J,358.3,34160,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,34160,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,34161,0)
 ;;=Z81.4^^131^1681^51
 ;;^UTILITY(U,$J,358.3,34161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34161,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence NEC
 ;;^UTILITY(U,$J,358.3,34161,1,4,0)
 ;;=4^Z81.4
 ;;^UTILITY(U,$J,358.3,34161,2)
 ;;=^5063362
 ;;^UTILITY(U,$J,358.3,34162,0)
 ;;=Z98.0^^131^1681^62
 ;;^UTILITY(U,$J,358.3,34162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34162,1,3,0)
 ;;=3^Intestinal Bypass/Anastomosis Status
 ;;^UTILITY(U,$J,358.3,34162,1,4,0)
 ;;=4^Z98.0
 ;;^UTILITY(U,$J,358.3,34162,2)
 ;;=^5063733
 ;;^UTILITY(U,$J,358.3,34163,0)
 ;;=Z91.128^^131^1681^61
 ;;^UTILITY(U,$J,358.3,34163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34163,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Other Reasons
